Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl — Stella

Home/Alzheimer Disease/

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Disease trials

Trial locations(1 site)

United States

Washington University School of Medicine, St Louis, Missouri

Key details

Sponsor

Washington University School of Medicine

Enrollment target

~60 participants

Started

November 2023

Primary completion

December 2026

Age range

18 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.